B-cell Malignancies clinical trials at UCSF
1 in progress, 0 open to eligible people
Showing trials for
CTX110 in Subjects With Relapsed or Refractory B-Cell Malignancies (CARBON)
Sorry, in progress, not accepting new patients
This is an open-label, multicenter, Phase 1/2 study evaluating the safety and efficacy of CTX110 in subjects with relapsed or refractory B-cell malignancies.
San Francisco, California and other locations
Last updated: